Tag Archives: Cancer Immunotherapy

Alternative Cancer Treatment, Cancer Care Tips, Living with Cancer, Uncategorized

Taking Care of Yourself: Stress-Reduction Techniques Help with Cancer Pain Management

Reduce Stress

Patients undergoing cancer treatment come to understand the close connection between their mental and physical well-being. Some people are turning to a 95-year-old Japanese stress-reduction technique to relieve the side effects of chemotherapy and radiation.

An Old Answer to a Current Problem

Reiki is a relaxation method that has been compared to “acupuncture without the needles.” While the patient lies flat, a Reiki practitioner places her hands on crucial areas of the body to improve the flow of energy and promote healing.

Many cancer patients who have undergone Reiki find that it helps them cope with anxiety, nausea and other common side effects of treatment. Some have talked about experiencing an overall feeling of calmness.

A Cancer Patient Speaks About Her Experience with Reiki

When Lewisburg, PA resident Erin Yust Brown was diagnosed with breast cancer, she recalled the comments of fellow yoga students regarding the benefits of Reiki. As Brown explains, the process treats the whole body as one, as opposed to the more limited approach of cancer treatment.

Brown’s practitioner, Nancy Giutini, refers to Reiki as “energy medicine” and uses the same methods that date back to its origin. Giutini emphasizes that Reiki is not a cure, but it’s been found to help patients by providing pain management and stress relief.

Personalized and Integrative Cancer Treatment at Issels®

Just as Reiki addresses the needs of the body as a whole, our immunotherapy cancer treatments focus on enhancing the body’s natural defenses. Contact us today to learn more about how we have helped a remarkable number of cancer patients achieve long-term remission.

 

Alternative Cancer Treatment, Cancer Research, Cancer Survivors, Immunotherapy, Immunotherapy for Cancer, Uncategorized

June is Cancer Immunotherapy Month

June is Cancer Immunotherapy Awareness Month
June is Cancer Immunotherapy Awareness Month

In the fight against cancer, immunotherapy has been a game-changer. The Society of Immunotherapy for Cancer (SITC) is recognizing June as Cancer Immunotherapy Month to recognize and promote the value of these treatments.

Putting Immunotherapy in the Public Eye

The SITC observes Cancer Immunotherapy Month by promoting public awareness of immunotherapy and sponsoring educational events for both healthcare professionals and patients.

Here are a few of the programs scheduled for the upcoming month:

• “Cancer Immunity and Immunotherapy” is being held as part of the annual meeting of the Federation of Clinical Immunology Societies. Presentations will focus on tumor immunology and therapies such as vaccines, CAR-T cells and checkpoint inhibitors.

• “Incorporating Radiation Oncology into Immunotherapy” is a two-day workshop exploring the challenges and opportunities of combining the different methods into one integrative treatment.

• “Rational Combinations 360º” is a comprehensive examination of combining therapies as it relates to business, clinical and scientific aspects.

How Can You Participate?

Everyone has been touched by cancer in one way or another. There are a number of ways you can support Cancer Immunotherapy Month.

• Join the Cancer Immunotherapy CONNECT Open Forum and share your stories with other members.

• Purchase a SITC Cure t-shirt.

• Post your support of immunotherapy for cancer research on Twitter, Facebook and other social media platforms.

• Donate to the Forward Fund for immunotherapy research.

State-of-the-Art Immunotherapy for Cancer at Issels®

Our founder, Dr. Josef M. Issels, was a pioneer in the development and use of immunotherapy. Visit our website for more information about Dr. Issels and our individually tailored non-toxic immunotherapy programs.

Alternative Cancer Treatment, Cancer Research, Cancer Treatment, Immuno-Oncology, Immunotherapy, Immunotherapy for Cancer, Living with Cancer, Uncategorized

The Cost of Some New Cancer Drugs Spiral Out of Reach for Some Patients

The Cost of Some Medications Is Rising
The Cost of Some Medications Is Rising

The last few years have brought exciting advances in immunotherapy for cancer, but innovation has come at a price … literally. Skyrocketing costs for cancer drugs are making them inaccessible for many who would benefit the most.

Cancer Drugs: The Price of Success

During the 10-year period between 2005 and 2015, Big Pharma’s pipeline of cancer drugs increased by 63 percent, with several reaching the market. As a result, the global market is projected to grow from $16.9 billion in 2015 to an astounding $75.8 billion in 2022.

But while competition generally serves to drive prices down, that’s not happening with the new cancer drugs. Factors such as market exclusivity, insurance plan structures and lack of head-to-head comparison studies combine to keep prices high.

One example is checkpoint inhibitors, which release the systemic “brakes” preventing the immune system from recognizing and attacking cancer cells. Bristol, Merck, Roche and Pfizer all have checkpoint inhibitors on the market, but each has an annual price tag approaching $150,000.

What’s the Answer?

Experts see no evidence that pharmaceutical companies, driven by the current free rein on pricing, are exploring more cost-effective solutions. President Donald Trump and lawmakers from both parties are prioritizing a search for methods to restrain spiraling cancer drug costs, ranging from more price negotiation to faster approval.

Issels® Leads the Field in Immunotherapy for Cancer

While the medical community and lawmakers grapple with the finances of immunotherapy for cancer, we have been successfully treating patients with individually developed non-toxic protocols for years. Contact us today to learn more about cancer vaccines, NK cells and other immunotherapy programs at Issels®.

Alternative Cancer Treatment, Cancer Research, Immunotherapy, Immunotherapy for Cancer

Immunotherapy Experts Share Opinions on the Future of Treatments

2 Comments
Sharing the Opinions of the Future

What has made cancer immunotherapy such a promising avenue of treatment and where will it be in the next five to 10 years? Jason Luke, M.D., an assistant professor of medicine at the University of Chicago, recently shared his opinions about the current and future state of immunotherapy.

Immunotherapy Makes the Type of Cancer Irrelevant

As Dr. Luke explains, immunotherapy is about the difference in the immune system’s response to cancer rather than the difference in the types of tumors. Researchers are focusing on the number of mutations rather than the mutations themselves to determine the quality of the baseline immune response.

New technologies such as gene expression profiling make it easier to measure data. The hope is that eventually this will lead to a broader application of immunotherapy as opposed to a cancer-specific one.

Why Does Immunotherapy Work So Well on Lung Cancer and Melanoma?

According to Dr. Luke, the popular hypothesis is that immunotherapy is particularly effective against lung cancer and melanoma due to mutations making these cancer cells stand out more vividly from healthy tissues so the immune system can readily detect them.

Combining Immunotherapy with Other Treatments

There appears to be three main phenotypes in cancer patients that dictate their response to antibodies, from low to medium to high. Dr. Luke feels that combining immunotherapy with chemo and targeted therapies offers the most potential for long-term benefits.

Issels®: The Past, Present and Future of Cancer Immunotherapy

Issels® has been in the forefront of state-of-the-art cancer immunotherapy treatments for decades. Visit our website to learn more about the history of Issels® and our personally developed programs.

 

Alternative Cancer Treatment, Cancer Research, Immunotherapy, Immunotherapy for Cancer

Immunotherapy Gives Hope to Cancer Patients

1 Comment
Training Your Immune System to Fight Off Cancer For You!
Immunotherapy

After years of research, scientists are still unable to pinpoint the causes and predictors of cancer with absolute certainty. The good news is that immunotherapy for cancer now offers hope for patients who previously had few options.

An Immunotherapy Success Story

One such patient was Tish Vigna. Four years ago she was diagnosed with stage 3 cancer in her left lung, despite being a physically fit non-smoker. She underwent a course of chemotherapy, radiation and surgery only to discover that the cancer had spread to her right lung.

Tish’s oncologist suggested that she enter a clinical trial of immunotherapy for cancer at Princess Margaret Hospital in Toronto. After months of treatment, doctors found that the tumors had shrunk in half and there has been no subsequent growth.

How Does Immunotherapy Work?

Immunotherapy is a process of boosting the ability of your own immune system to fight cancer cells naturally. These treatments generally fall within two categories:

  • With adoptive T-cell therapy, doctors extract the attacking T-cells from a patient’s tumor to increase their numbers. The cells are then re-entered into the patient’s system where they are now better equipped for battle.
  • The immune system has a braking mechanism that prevents it from going into overdrive. Checkpoint inhibitors disable these brakes so the T-cells can attack cancer cells with full force.

Issels®: Leading the Way with Immunotherapy

While immunotherapy for cancer has been making a big splash in the medical community recently, Issels® has been successfully using these personally tailored treatments for decades. Contact us today for more information about our immunotherapy programs such as cancer vaccines and NK cells.

Alternative Cancer Treatment, Cancer Research, Immunotherapy

Nanodiscs May Personalize Immunotherapy for Cancer in the Near Future

Training Your Immune System to Fight Off Cancer For You!
Training Your Immune System to Fight Off Cancer For You!

One of the highlights of immunotherapy for cancer is that the protocols are personally tailored to address your individual needs. A research team at the University of Michigan recently developed a way to customize cancer vaccines that holds promise for both current treatment and long-term immunity.

“Training” the Immune System

Immunotherapy for cancer focuses on helping your own immune system battle cancer cells. The vaccine created by the University of Michigan team uses synthetic high-density lipoproteins called nanodiscs to train the immune system to recognize and attack cancer cells.

Nanodiscs use patient-specific genetic mutations, or tumor neoantigens, to trigger production of T-cells by the immune system. The T-cells then use the genetic material in the nanodiscs to target the cancer cells.

The study involved treating mice suffering from melanoma and colon cancer with a combination of checkpoint inhibitors and the nanodisc vaccine. Not only were most of the tumors eliminated, the mice remained tumor-free after the same cancer cells were reintroduced into their systems after 70 days.

University of Michigan Goes All-In on Nanodisc Research

Encouraged by the results of the test, the University of Michigan has created a biotech company named EVOQ Therapeutics to concentrate on developing and refining the nanodisc vaccine. Plans are to conduct further studies on animals before moving into clinical trials.

Issels®: Blazing the Immunotherapy for Cancer Trail

Cancer vaccines are just one of the innovative non-toxic treatments we employ at Issels®. Visit our website to learn more about our specialized testing methods and individualized integrative programs.